¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"human development"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® development ÇÑ±Û ¹ß´Þ, ¹ß»ý, ¹ßÀ°
¼³¸í   
  1. ¹ß´Þ. ½É½ÅÀÇ ÇüÅ¿͠Àç´ÉÀÇ »ó½ÂÀûÀΠº¯È­°úÁ¤. ¼ºÀå°ú ¸Å¿ì À¯»çÇÑ °³³äÀ¸·Î, ¶§·Î´Â °°Àº ¶æÀ¸·Î ¾²À̴ °æ¿ìµµ ÀÖ´Ù. ±×·¯³ª ¼ºÀåÀº °³Ã¼ÀÇ ¹ßÀ°¿¡ µû¸£´Â º¯È­, Áï °è¿­ÀûÀ¸·Î ¾çÀûÀΠÁõ°¡·Î¼­ ±â¼úÇϴ °æ¿ì¿¡ ¸¹ÀÌ ¾²À̰í, ¹ß´ÞÀº À̿͠°°Àº º¯È­¸¦ ¾çÀûÀΠ¸é»Ó¸¸ ¾Æ´Ï¶ó, ±¸Á¶³ª Àç´ÉÀÌ ºÐÈ­-º¹ÀâÈ­-Á¤¹ÐÈ­-À¯´ÉÈ­-ÅëÇÕÈ­µÇ¾î °¡´Â °ÍÀ¸·Î¼­ ±â¼úÇϴ °æ¿ì¿¡ ´õ¿í ¸¹ÀÌ ¾²À̴ °æÇâÀÌ ÀÖ´Ù. ±×¸®°í ¹ß´ÞÀ̶ó°í Çϴ °³³äÀº, À¯±âüÀÇ ¹ßÀ°¿¡ ´ëÇØ¼­¸¸ ¾²À̴ °ÍÀÌ ¾Æ´Ï¶ó, ¹«»ý¹°À̳ª ¹°¸®Àû-È­ÇÐÀû Çö»ó¿¡ ´ëÇØ¼­µµ ¶Ç´Â »çȸÀû-¹®È­Àû Çö»ó¿¡ ´ëÇØ¼­µµ ½Ã°£Àû º¯È­¹ßÀüÀ» ¼ö¹ÝÇϴ °æ¿ì¿¡ Àû¿ëµÇ´Â °³³äÀÌ´Ù. 2. ¹ßÀ°. ¹ßÀ°°úÁ¤¿¡´Â ´ÙÀ½°ú °°Àº ÀϹÝÀûÀΠ¿øÄ¢À» º¸ÀδÙ. ¨ç ¹ßÀ°Àº Áú¼­Á¤¿¬ÇϰԠÀÏÁ¤ÇÑ ¼ø¼­¸¦ °®´Â´Ù. ¨è ¹ßÀ°Àº ¿¬¼ÓÀûÀ̳ª ÀÏÁ¤ÇÑ ¼Óµµ·Î ÁøÇàÇϴ °ÍÀº ¾Æ´Ï´Ù. ¨é ¹ßÀ°¿¡´Â ¹ßÀ°»ó Áß¿äÇÑ °¨¼ö±â¿Í ÀÓ°è±â°¡ ÀÖ´Ù.
¿µ¹® beta human chorionic gonadotropin ÇÑ±Û º£Å¸ »ç¶÷À¶¸ð¼º »ý½Ä»ùÀÚ±ØÈ£¸£¸ó
¼³¸í   
  Å¹ݼ¼Æ÷¿¡¼­ ¸¸µé¾îÁö´Â È£¸£¸ó. ±â´ÉÀº ÀÓ½ÅÀÇ Ãʱ⿡ È²Ã¼(¿ø·¡ ³­ÀÚ¸¦ ½Î°í ÀÖ´ø ¼¼Æ÷µéÀÌ ¹è¶õÀÌ ÀϾ¼­ ³­ÀÚ°¡ ºüÁ®³ª°£ ÈÄ ÁÖ¸Ó´Ï ¸ð¾çÀ» ÀÌ·é °Í. ÀÓ½ÅÃʱ⿡ ÀÓ½ÅÀÇ À¯Áö¿¡ ÇÊ¿äÇѠȣ¸£¸óÀ» »ý¼ºÇÑ´Ù)ÀÇ À¯Áö¿¡ ±â¿©Çϰí, Å¾ÆÀÇ °íȯÁ¶Á÷¿¡¼­ ³²¼ºÈ£¸£¸óÀÌ ºÐºñµÇ´Â °ÍÀ» ÃËÁø½ÃŲ´Ù. ¶Ç À̰ÍÀº ÀÓ½ÅÃʱâÀÇ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼­ ¸¹Àº ¾çÀÌ °ËÃâµÇ¹Ç·Î À̰ÍÀ» ÀÌ¿ëÇØ¼­ ÀÓ½ÅÀÇ ¿©ºÎ¸¦ ¼Õ½±°Ô Á¶»çÇÒ ¼ö°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cognitive development
    ÀÎÁö¹ß´Þ
  • communicative development
    ÀÇ»ç¼ÒÅë¹ß´Þ
  • community development
    Áö¿ª»çȸ°³¹ß
  • curriculum development
    ±³À°°úÁ¤°³¹ß
  • development
    1. Çö»ó 2. Àü°³ 3. ¹ß»ý, ¹ßÀ°, ¹ß´Þ 4. °³¹ß 5. ¹ß»ö
  • development quotient
    ¹ß´ÞÁö¼ö
  • direct development
    Á÷Á¢¹ßÀ°
  • ego development
    ÀھƹߴÞ
  • emotional development
    °¨Á¤¹ß´Þ
  • mental development
    Á¤½Å¹ß´Þ
  • psychosocial development
    Á¤½Å»çȸ¹ß´Þ
  • sexual development
    ¼º±â´É¹ß´Þ
  • antihemophilic human plasma
    Ç×Ç÷¿ìº´Ç÷Àå
  • anti-human globulin
    Ç×»ç¶÷±Û·ÎºÒ¸°, Ç×ÀÎü±Û·ÎºÒ¸°
  • enteric cytopathogenic human orphan virus
    ¿¡ÄÚ¹ÙÀÌ·¯½º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • development
    ¹ß´Þ, ¹ß»ý, ¹ßÀ°
  • human experiment
    ÀÎü½ÇÇè
  • human menopausal gonadotropin
    »ç¶÷Æó°æ»ý½Ä»ùÀÚ±ØÈ£¸£¸ó
  • human
    »ç¶÷, Àΰ£
  • human papilloma virus test
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º°Ë»ç
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human papilloma virus
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-human globulin
    Ç×ÀÎü±Û·ÎºÒ¸°, Ç×»ç¶÷±Û·ÎºÒ¸°
  • human histocompatibility antigen
    »ç¶÷Á¶Á÷ÀûÇÕÇ׿ø
  • human leukocyte antigen
    »ç¶÷¹éÇ÷±¸Ç׿ø
  • human leukocyte antigen complex
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
  • enteric cytopathogenic human orphan virus
    ¿¡ÄÚ¹ÙÀÌ·¯½º
  • human ecology
    Àΰ£»ýÅÂÇÐ
  • human genetics
    ÀηùÀ¯ÀüÇÐ
  • human leukocyte antigen complex gene
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕüÀ¯ÀüÀÚ
  • human rabies immune globulin
    »ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°
  • immune human serum globulin
    (¢¡immune globulin) ¸é¿ª±Û·ÎºÒ¸°
  • human
    »ç¶÷, Àΰ£
  • human blood index
    »ç¶÷Ç÷¾×Áö¼ö
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human placental lactogen
    ŹÝÁ¥»ùÀÚ±ØÈ£¸£¸ó
  • human T-cell lymphotropic virus
    »ç¶÷Ƽ¼¼Æ÷¸²ÇÁģȭ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arrested development
    ¹ß´ÞÁ¤Áö.
  • personality development
    ÀÎ°Ý ¹ß´Þ
  • postnatal development
    »ýÈĹßÀ°(¡­Û¡ëÀ).
  • prenatal development
    Ãâ»ýÀü¹ßÀ°(¡­Û¡ëÀ).
  • primary bone development
    ÀÏÂ÷»À¹ß»ý
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ.
  • psychosocial development
    Á¤½Å»çȸÀû ¹ß´Þ
  • ECHO virus =enteric cytopathogenic human orphan v.
    ¿¡ÄÚ¹ÙÀÌ·¯½º(¼Ó).
  • Enteric cytopathogenic human orphan virus =ECHO v.
    ¿¡ÄÚ¹ÙÀÌ·¯½º(¼Ó).
  • Enteric cytopathogenic human orphan virus =ECHO virus
    ¿¡ÄÚ¹ÙÀÌ·¯½º
  • HCG=>human chorionic gonadotropin
    »ç¶÷À¶¸ð¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó
  • HIV => human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • HIV=>human immunodeficiency virus
    ÀÎü ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • HLA => human leukocyte antigen
    ÀÎüÁ¶Á÷ÀûÇÕÇ׿ø<ÀÎü¹éÇ÷±¸Ç׿ø>
  • HLA= human leukocyte antigen ; hist ocompatibility antigens ; tran splan tation antigens
    HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, ÀιéÇ÷±¸Ç׿ø.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arrested development
    ¹ß´ÞÁ¤Áö.
  • atypical development
    ºñÁ¤Çü ¹ß´Þ
  • bone development =b. formation
    °ñ¹ß»ý(ÍéÛ¡ßæ).
  • child development
    ¼Ò¾Æ¹ß´Þ.
  • cognitive development
    ÀÎÁö¹ß´Þ(ìãò±Û¡Ó¹)
  • colo(u)r development
    ¹ß»ö.
  • communicative development
    ÀÇ»ç¼ÒÅë ¹ß´Þ(ëòÞÖáÂ÷×Û¡Ó¹)
  • community development
    Áö¿ª»çȸ°³¹ß (ÊÙ˧ËÑ).
  • curriculum development
    °úÁ¤ÀÛ¼º(Ë´ËøËöËÛ), °úÁ¤°³¹ß.
  • development
    ¹ß´Þ(Û¡Ó¹)
  • development
    ¹ß»ý, ¹ßÀ°(Û¡ëÀ), Àü°³(î÷ËÒ), Çö»ó(úÞßÀ).
  • development history
    ¹ßÀ°¿ª(»ç).
  • development quotient =DQ
    ¹ß´ÞÁö¼ö.
  • development quotient =DQ
    ¹ß´ÞÁö¼ö.
  • ego development
    ÀھƹߴÞ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Human placenta
    »ç¶÷ŹÝ
    [¿¾ ¿ë¾î] ÀÎŹÝ
  • Membranous bone development
    ¸·»À¹ß»ý
    [¿¾ ¿ë¾î] ¸·¼º°ñ¹ß»ý
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • human flea(=Pulex irritans)
    »ç¶÷º­·è
  • human parasitology
    ÀÎü±â»ýÃæÇÐ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • human chorionic gonadotropin
    ÀÎü À¶¸ð¼º ¼º¼± ÀÚ±Ø(ìÑô÷ëÖÙ¾àõàõàÊí©Ð½) È£¸£¸ó
  • human lactogen
    ÀÎü(ìÑô÷) ¶ôÅäÀü
  • continuous development
    ¿¬¼ÓÀü°³(ææáÙî÷ËÒ)
  • displacement development
    ´ëÄ¡Àü°³(ÓÛöÇî÷ËÒ) (ÔÒ) displacement chromatography
  • stepwise development
    ´Ü°èÀû Àü°³(Ó«Í­îÜî÷ËÒ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HLA[=human leukocyte antigen]
    HLAÇ׿ø, Àΰ£¹éÇ÷±¸Ç׿ø
  • development
    ¹ß»ý, ¹ßÀ°, Àü°³, ¡ìÇʸ§ÀÇ¡íÇö»ó
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPL human parotid lysozyme; human peripheral lymphocyte; human placental lactogen
NICHHD National Institute of Child Health and Human Development
OHD hydroxyvitamin D; Office of Human Development; Ondine-Hirschsprung disease; organic heart disease
OHDS Office of Human Development Services
HAM hearing aid microphone; helical axis in motion; human albumin microsphere; human alveolar macrophage...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NICHD National Institute of Child Health and Human Development
PEG-rHuMGDF PEGylated recombinant human megakaryocyte growth and development factor
BSID Bayley Scale of Infant Development
CPD Continuing Professional Development
CARDIA Coronary Artery Risk Development In Young Adults
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 4128
    JournalTitle: Human development.
    MedAbbr: Hum Dev
    ISSN: 0018-716X
    ESSN:
    IsoAbbr:
    NlmId: 12445
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • child development
    ¼Ò¾Æ ¹ß´Þ
  • cognitive development
    ÀÎÁöÀû ¹ß´Þ
  • development
    ¹ß»ý, ¹ßÀ°, Àü°³, Çö»ó
    1. ¹ß´Þ, ¹ß»ý, ¹ßÀ°, Çö»ó. ¹ßÀ°°ú ºÐÈ­ÀÇ °úÁ¤. 2. Çö»ö, Àü°³. 3. ³ë±¤¿¡ ÀÇÇØ °¨±¤¸·ÀÇ À¯Á¦¸· ¼Ó¿¡ »ý±ä Àá»óÀ» °¡½ÃÀÇ »óÀ¸·Î ¸¸µå´Â ÀÏ. ÃÔ¿µÀÌ ³¡³­ Çʸ§¿¡´Â ´«¿¡ º¸ÀÌÁö ¾ÊÀ¸³ª Àá»óÀ̶ó´Â ÇÇ»çü°¡ ±â·ÏµÇ¾î ÀÖ´Ù. ÀÌ¿Í °°ÀÌ ±â·ÏµÈ ´«¿¡ º¸ÀÌÁö ¾Ê´Â Çʸ§À» ¾Ï½Ç¿¡¼­ Çö»ó¾×À̶ó´Â ¾àǰ¿¡ ÀÏÁ¤½Ã°£ ´ã°¡µÎ¸é ´«¿¡ º¸ÀÌÁö ¾Ê´ø ±â·Ï È­»ó
  • development disorder
    ¹ßÀ° Àå¾Ö
  • development of speech and language
    ÀÇ»ç ¼ÒÅëÀÇ ¹ß´Þ
  • ectopoc development
    ÀÌ¼Ò ¹ßÀ°
  • embryonic development
    ¹è ¹ß»ý
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • incomplete development
    ºÒ¿ÏÀüÇÑ ¹ßÀ°
  • personality development
    ¼º°Ý ¹ß´Þ
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ
  • sensory development
    °¨°¢ ¹ß´Þ, Áö°¢ ¹ß´Þ
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü ¹éÇ÷±¸ Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü ¹éÇ÷±¸ Ç׿ø
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
human development Continuous sequential changes which occur in the physiological and psychological functions during the individual's life.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Bayley Scales of Infant Development A psychological test used to measure the developmental progress of infants over the first two and one-half years of life; consists of three scales: mental, motor, and behaviour record.
(05 Mar 2000)
bone development Gross development of bones from foetus to adult. It includes osteogenesis, which is restricted to formation and development of bone from the undifferentiated cells of the germ layers of the embryo. It does not include osseointegration.
(12 Dec 1998)
maxillofacial development The process of growth and differentiation of the jaws and face.
(12 Dec 1998)
child development The continuous sequential physiological and psychological maturing of the child from birth up to but not including adolescence. It includes healthy responses to situations, but does not include growth in stature or size (= growth).
(12 Dec 1998)
child development disorders, pervasive Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
(12 Dec 1998)
personality development Growth of habitual patterns of behaviour in childhood and adolescence.
(12 Dec 1998)
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
pervasive development disorder <neurology, psychiatry> A large group of developmental disabilities which are neurological disorders, usually of unknown cause.
Characteristics include reduced abilities to understand language and communicate normally, reduced ability to socially interact with others in a normal manner, and limited variety in activities and interests. Individuals will also often respond in unusual ways to sensations, engage in repetitive activities, and resist changes to the environment or to daily routines.
Types of pervasive development disorder include autism, Retts Syndrome, Hellers Syndrome, and Aspergers Syndrome.
Acronym: PDD
(12 Jan 1998)
consensus development conference Designation for summary statements representing the majority and current agreement of physicians, scientists, and other professionals meeting to reach a consensus on a selected subject.
(12 Dec 1998)
consensus development conferences Presentations of summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus--often with findings and recommendations--on a subject of interest. The conference, consisting of participants representing the scientific and lay viewpoints, is a significant means of evaluating current medical thought and reflects the latest advances in research for the respective field being addressed.
(12 Dec 1998)
consensus development conferences, nih Articles on conferences sponsored by nih presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for nih consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the nih office of medical applications of research (omar).
(12 Dec 1998)
program development The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development).
(12 Dec 1998)
psychosexual development The stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods.
(12 Dec 1998)
staff development The process by which the employer promotes staff performance and efficiency consistent with management goals and objectives.
(12 Dec 1998)
state health planning and development agencies Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Human Development - »õâ Continuous sequential changes which occur in the physiological and psychological functions during the life-time of an individual.
    Synonyms : Development, Human
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • development
    ¹ß´Þ,¹ßÀü,°³¹ß
  • Development Assistance Committee
    °³¹ß ¿øÁ¶ À§¿øÈ¸(OECD¼Ò¼Ó ±â°ü,¾à DAC)
  • Development Decade
    À¯¿£(Á¦3¼¼°è)°³¹ßÀÇ 10³â
  • Development theory
    (»ý)(¶ó¸¶¸£Å©ÀÇ)ÁøÈ­·Ð
  • InterAmerican Development Bank
    ¹ÌÁÖ °³¹ßÀºÇà
  • International Bank for Reconstruction and Development
    ±¹Á¦ ºÎÈï°³¹ßÀºÇà(IBRD)ÅëĪ(the world bank)
  • International Development Association
    (UNÀÇ)±¹Á¦ °³¹ß Çùȸ(IDA)
  • development
    ¹ß´Þ;¹ßÀü;Àü°³
  • development area
    »ê¾÷ °³¹ß Áö±¸
  • economic development zone
    (Áß°øÀÇ)°æÁ¦ °³¹ß±¸
  • housing development
    Áý´ÜÁÖÅÃ(¿ëÁö);ÁÖÅôÜÁö
  • research and development
    ¿¬±¸¿Í °³¹ß
  • ribbon development
    ´ë»ó°³¹ß(µµ½Ã¿¡¼­ ±³¿Ü·Î °£¼± µµ·Î¸¦ µû¶ó ¹«Áú¼­ÇÏ°Ô »¸¾î°¡´Â ÁÖÅà °ÇÃà)
  • self development
    Àڱ⠹ßÀü(°³¹ß)
  • string development
    =RIBBON DEVELOPMENT
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á